Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Corvus Pharmaceuticals complete Phase 2 trial for soquelitinib in atopic dermatitis by end of 2025?  | Binary | 3 | 6 days ago | ||
Will Corvus secure over $20 million in funding for soquelitinib by end of 2025? | Binary | 3 | 6 days ago | ||
Will Corvus announce a partnership or acquisition for soquelitinib by end of 2025? | Binary | 2 | 6 days ago | ||
What will be the outcome of Phase 2 trial results for soquelitinib by end of 2025? | Categorical | 2 | 6 days ago | ||
What will be the market approval status of soquelitinib by end of 2026? | Categorical | 2 | 6 days ago | ||
How will Corvus stock price change post Phase 2 results announcement? | Categorical | 2 | 6 days ago |